Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2a,Condition 2b,Condition 2c 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,5,,CMO:0000551,plasma aldosterone level,,,,389,pg/ml,86.0,192.3018,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days),101266,unilateral nephrectomy (for 42 days),,, 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,8,,CMO:0000551,plasma aldosterone level,,,,492,pg/ml,46.0,130.1076,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days),101267,unilateral nephrectomy (for 42 days),controlled candesartan content drinking water (1 mg/kg/d) (for 28 days),, 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,9,,CMO:0000551,plasma aldosterone level,,,,369,pg/ml,54.0,162.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days),101268,unilateral nephrectomy (for 42 days),controlled delapril content drinking water (30 mg/kg/d) (for 28 days),, 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,5,,CMO:0000551,plasma aldosterone level,,,,581,pg/ml,92.0,205.7183,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days),101269,unilateral nephrectomy (for 42 days),controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days),, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",blood aldosterone amount,,RS:0000681,SD,male,0 days,11,,CMO:0000551,plasma aldosterone level,,-,,526,pg/ml,78.3929,260.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days),101556,unilateral nephrectomy (between 12 and 14 days),,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",blood aldosterone amount,,RS:0000681,SD,male,0 days,5,,CMO:0000551,plasma aldosterone level,,,,181,pg/ml,55.4545,124.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days),101557,unilateral nephrectomy (between 12 and 14 days),enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days), 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",blood aldosterone amount,,RS:0000681,SD,male,0 days,5,,CMO:0000551,plasma aldosterone level,,,,487,pg/ml,50.9823,114.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days),101558,unilateral nephrectomy (between 12 and 14 days),enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),aldosterone (30-40 mg/kg/d) (between 12 and 14 days)